Trial Profile
Phase II Trial of Seizure Prophylaxis in Brain Tumor Patients Undergoing Neurosurgical Procedure
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 17 Apr 2023
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary) ; Levetiracetam (Primary)
- Indications Seizures
- Focus Therapeutic Use
- 23 Mar 2021 Status changed from recruiting to discontinued.
- 29 Sep 2020 Status changed from suspended to recruiting.
- 20 Apr 2020 Status changed from recruiting to suspended.